Pharmacokinetic interactions between herbal medicines and drugs;Interações farmacocinéticas entre as plantas medicinais Hypericum perforatum, Gingko biloba e Panax gingseng e fármacos tradicionais

Acta Farmaceutica Bonaerense

Volumn 23, Issue 4, 2004, Pages 567-578

  De Oliveira, Ana Elisa ^a,b   Dalla Costa, Teresa ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

Author keywords

Gingko biloba; Herbal medicine and drugs; Hypericum perforatum; Panax ginseng; Pharmacokinetic interactions

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; CAFFEINE; CARBAMAZEPINE; CHLORZOXAZONE; CYCLOSPORIN; CYTOCHROME P450 1A2; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; DEBRISOQUINE; DEXTROMETHORPHAN; DIGOXIN; ETHINYLESTRADIOL; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; MIDAZOLAM; NICARDIPINE; NIFEDIPINE; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; THEOPHYLLINE; TOLBUTAMIDE; TRAZODONE; UNINDEXED DRUG; WARFARIN;

BRAZIL; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; DRUG CROSS REACTIVITY; DRUG EFFICACY; DRUG SAFETY; GINKGO BILOBA; GINSENG; HUMAN; HYPERICUM PERFORATUM; MEDICINAL PLANT; REVIEW; RISK ASSESSMENT;

EID: 14144256314     PISSN: 03262383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Miller, L.G. (1998) Arch. Intern. Med. 158: 2200-11.
2. Fugh-Berman, A. (2000) Lancet 355: 134-8.
3. Ioannides, C. (2002) Xenobiotica 32: 451-78.
4. Abebe, W. (2002) J. Clin. Pharm. Ther. 27: 391-401.
5. Robbers, J. E., M.K. Speedie & V.E. Tyler (1997) "Farmacognosia e Farmacobiotecnologia" Ed. Premier, São Paulo.
6. Izzo, A.A. & E. Ernst (2001) Drugs 61: 2163-75.
7. Bhattaram, V.A.; U. Graefe, C. Kohlert, M. Veit & H. Derendorf (2002) Phytomedicine 9: 1-33.
8. Fugh-Berman, A. & E. Ernst (2001) J. Clin. Pharmacol. 52: 587-95.
9. Marcolin, M.A. (1998) "Interações farmacológicas com drogas psiquiátricas", Medsi, Rio de Janeiro.
10. Patsalos, P.N. & E. Perucca (2003) Lancet Neurol. 2(6): 347-356.
11. Zhu, M.; L.S.N. Chan, Q. Chang, S. Chang & R.C. Li (1999) J. Pharm. Pharmacol. 51: 175-80.
12. Mai, I., H. Krüger, K. Budde, A. Johne, J. Brockmöller, H-H. Neumayer & I. Roots (2000) Int. J. Clin. Pharmacol. Ther. 38: 500-2.
13. Kuze Rates, S.M. & Silva, G.G. Dados sobre medicamentos fitoterápicos simples registrados na ANVISA e publicados no Diário Oficial da União (D.O.U. - Brasil) no período de 01/01/1998 a 30/06/2003. Comunicação pessoal.
14. BRASIL. ANVISA (2004). http://www.anvisa. gov, acessado em 20/01/2004.
15. Piperopoulos, G., R. Lotz, A. Wixforth, T. Schmierer & K.P. Zeller (1997) J. Chromatogr. B. 695: 309-16.
16. Draves, A.H. & S.E. Walker (2000) J. Chromatogr. B 749: 57-66.
17. Dürr, D., B. Stieger, G.A. Kullak-Ublick, K.M. Rentsch, H.C. Steinert, P.J. Meier & K. Fattinger (2000) Clin. Pharmacol. Ther. 68: 598-604.
18. Johne, A., J. Brockmoller, S. Bauer, A. Maurer, M. Langheinrich, & I. Roots (1999) Clin. Pharmacol. Ther. 66: 338-45.
19. Schinkel, A.H., E. Waenar, L. Van Deemter, C.A.A.M. Mol & P. Borst (1995) J. Clin. Invest. 96: 1698-705.
20. Conseil, G., H. Baubichon-Cortay, G. Dayan, J.M. Jault, D. Barron, & A. Di Pietro (1998) Proc. Nat. Acad. Sci. 95: 9831-6.
21. Ruschitzka, F., P.J. Meier, M. Turina, T.F. Lüscher & G. Noll (2000) Lancet 355: 548-9.
22. Piscitelli, S.C., A.H. Burstein, D. Chaitt, R.M. Alfaro & J. Falloon (2000) Lancet 355: 547-8.
23. De Maat, M.M., R.M. Hoetelmans, R.A. Matht, E.G. Van Gorp, P.L. Meenhorst, J.W. Mulder & J.H. Beijnen (2001) Aids 15: 420-5.
24. Fitzsimmons, M.E & J.M. Collins (1997) Drug Metabol. Disp. 25. 256-66.
25. Vue, Q. & C. Bergquist (2000) Lancet 355: 576-7.
26. Guengerich, F.P. (1988) Mol. Pharmacol. 33: 500-8.
27. Hall, S.D., Z.Q. Wang, S.M. Huang, M.A. Hamman, N. Vasavada, A.Q. Adigun, J.K. Hilligoss, M. Miller & J.C. Gorski (2003) Clin. Pharmacol. Ther. 74: 525-35.
28. Nebel, A., B.J. Schneider, R.K. Baker & D.J. Kroll (1999) Annals Pharmacother. 3: 502.
29. Furh, U., J. Doehmer, N. Battula, C. Wolfel, C. Kudla, Y. Keita & A.H. Staib (1992) Biochem. Pharmacol. 43: 225-35.
30. Markowitz, J.S., C.L. De Vane, D.W. Boulton, S.W. Carson, Z. Nahas & S.C. Risch (2000) Life Sci. 66: 133-9.
31. Smith, M.; K.M. Lin & Y.P. Zheng (2001) Am. Soc. Clin. Pharmacol. Ther. Poster Session III 69: 86.
32. Kaminsky, L.C. & Z.Y. Zhang (1997) Pharmacol. Ther. 73: 67-74.
33. Burstein, A.H., R.L. Horton, T. Dunn, R.M. Alfaro, S.C. Piscitelli & W. Theodore (2000) Clin. Pharmacol. Ther. 68: 605-12.
34. Roots, I., A. Johne, J. Schimder, A. Brockmöller, A. Maurer, E. Störmer & F. Donath (2000) Clin. Pharmacol. Ther. 67: 69.
35. Venkatakrishnan, K., D.J. Greenblatt, L.L., Von Moltke, J. Schmider, J.S. Harmatz & R.I. Shader (1998) J. Clin. Pharmacol. 38: 112-21
36. Venkatakrishnan, K., L.L. Von Moltke, & D.J. Greenblatt (1999) J. Clin. Pharmacol. 39: 567-77.
37. Wang, Z., C. Gorski, M.A. Hamman, S. Huang, L.J. Lesko & S.D. Hall (2001) Clin. Pharmacol. Ther. 70: 317-26.
38. Gurley, B.J., S.F. Gardner, M.A. Hubbard, D.K. Williams, B. Gentry, Y. Cui & C.Y.W. Ang (2002) Clin. Pharmacol. Ther. 72: 276-87.
39. Brasil. Anvisa - RE 357 (28/02/2002) Apreensão, em todo território nacional, de qualquer produto farmacêutico a base de Erva de São João (Hypericum perforatum) que não possuam tarja vermelha contendo os dizeres "Venda sob prescrição médica" (http://www.anvisa.gov)
40. Galluzzi, S., O. Zanetti, G. Binetti, G., M. Trabucchi & G.B. Frisoni (2000) J. Neurol. Neurosurg. Psychiatry 68: 679-80.
41. Markowitz, J.S., J.L. Donovan, L. Devane, L. Sipkes & K.D. Chavin (2003) J. Clin. Psychopharmacol. 23: 576-81.
42. Shinozuka, K., K. Umegaki, Y. Kubota, N. Tanaka, H. Mizuno, J. Yamauchi, K. Nakamura & M. Kunimoto (2002) Life Sci. 70: 2783-92.
43. Henderson, G.L., M.R. Harkey, M.E. Gershwin, R.M. Hackman, J.S. Stern & D.M. Stresser (1999) Life Sci. 65: 209-14.
44. Simões, C.M.O., E.P. Schenkel, G. Gosman, J.C.P. Mello, L.A. Ments & P.R. Petrovick (2003) "Farmacognosia: da planta ao medicamento", 5. ed., Editora da UFRGS/Editora UFSC, Porto Alegre/Florianopolis
45. Williamson, E.M. (2001) Phytomedicine 8: 401-9.
46. Hsiu, S.L., Y.C. Hou, Y.H. Wang, C.W. Tsao, S.F. Su & P.D.L. Chao (2002) Life Sci. 72: 227-35.
47. Cai, Y.N., D. Bennett, R.V. Nair, O. Ceska, M.J. Ashwoodsmith & J. Digiovanni (1993) Chem. Res. Toxicol. 6: 872-9.
48. Heck, A.M., B.A. Dewitt & A.L. Lukes (2000) Am. J. Health-Syst. Pharm. 57(13):1221-1227
49. Moghadasian, M.H. (2000) Life Sci. 67: 605-15.
50. Benzi, G. & A. Ceci (1997) Pharmacol. Res. 35: 56-66.
51. Brasil. Anvisa-RDC 48 (16/03/2004) Registro de medicamentos fitoterápicos (http://www.anvisa.gov)
52. Di Stasi, L.C., G.P. Oliveira, M.A. Carvalhaes, M. Queiroz-Junior, O.S. Tien, S.H. Kakinami & M.S. Reis (2002) Fitoterapia 73: 69-91.